Daegu Techno Park (Daegu TP) successfully conducted a global market expansion support program in Ho Chi Minh City, Vietnam, for regional medical AI companies. The program was carried out as part of the
"K-Health National Medical AI Service and Industrial Ecosystem Development Project," supported by the
Ministry of Science and ICT (MSIT) ,
Daegu Metropolitan City , and the
National IT Industry Promotion Agency (NIPA) . The
Daejeon Information & Culture Industry Promotion Agency and
Gwangju Technopark also participated in the initiative. Three companies from —
KOTRAS ,
Shilla System , and
ThomasTone —took part in the program. During the visit, they met with local medical institutions, including
Ho Chi Minh City University Medical Center , and explored collaboration opportunities with Vietnamese healthcare providers and distributors through business meetings held alongside
ICTCOMM 2026 .
1. KOTRAS showcased its AI-powered rehabilitation solution,
R-BOT Plus , designed for stroke survivors and patients with neurological disorders.
2. ThomasTone introduced its AI-based digital oral healthcare solutions,
Denti-Check and
Denti-i , and signed Memorandums of Understanding (MOUs) with
Hong Bang International University and local dental healthcare institutions. The company is also in discussions to conduct pilot projects with additional medical institutions.
3. Shilla System introduced its AI-powered orthopedic image analysis software,
Pine-DX , and discussed potential collaboration on clinical validation and commercialization with a specialized pediatric medical institution and buyers in Vietnam, further enhancing its prospects for overseas market expansion.
Daegu TP explained that the program provided a practical global support framework by integrating clinical validation at medical institutions, networking with overseas healthcare professionals, buyer discovery, and export consultations, thereby strengthening participating companies' foundation for entering international markets. In September, the organizaztion plans to launch another global commercialization support program centered on Singapore, connecting participating companies with overseas medical institutions and global biotechnology companies.
